The effectiveness and safety of corticosteroid therapy for IgA nephropathy with crescents: a prospective, randomized, controlled study
Abstract Background Pozzi protocol (methylprednisolone intravenous infusion in 1st-3rd-5th months and oral steroid for 6 months) has been thought to be the classic therapy for IgA nephropathy (IgAN) patients with proteinuria> 1.0 g/24 h. There is no consensus on the treatments for IgAN with activ...
Main Authors: | Mengjun Liang, Liping Xiong, Aihua Li, Jiafan Zhou, Yajuan Huang, Miaofang Huang, Xing Zhang, Hongrui Shi, Ning Su, Yi Wei, Zongpei Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-01-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12882-022-02661-6 |
Similar Items
-
Nomogram for the prediction of crescent formation in IgA nephropathy patients: a retrospective study
by: Zaoqiang Lin, et al.
Published: (2023-09-01) -
Crescents proportions above 10% are associated with unfavorable kidney outcomes in IgA nephropathy patients with partial crescent formation
by: Dingxin Di, et al.
Published: (2023-12-01) -
A novel clinical−radiomic nomogram for the crescent status in IgA nephropathy
by: Xiachuan Qin, et al.
Published: (2023-01-01) -
Crescents and IgA Nephropathy: A Delicate Marriage
by: Hernán Trimarchi, et al.
Published: (2022-06-01) -
Clinicopathologic characteristics and outcomes of IgA nephropathy patients with different proportions of crescent
by: Chun-hua Liu, et al.
Published: (2024-01-01)